What conditions might cause a low HbA1c?

Low HbA1c can result from conditions affecting red blood cells (anemia, blood loss), certain medications, liver/kidney disease, or rare genetic variants. While often overlooked compared to high HbA1c, understanding low levels is crucial for accurate diabetes diagnosis and overall health assessment.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding HbA1c and Why Low Levels Matter

Hemoglobin A1c (HbA1c) is a blood test that measures your average blood sugar levels over the past 2-3 months. It works by measuring the percentage of hemoglobin proteins in your red blood cells that have glucose attached to them. While much attention is given to high HbA1c levels as an indicator of diabetes, abnormally low HbA1c levels can also signal underlying health issues that deserve attention.

A normal HbA1c range is typically between 4.0% and 5.6%, with levels below 4.0% considered low. However, what constitutes "too low" can vary based on individual circumstances and the presence of other health conditions. Understanding the causes of low HbA1c is essential because it can affect diabetes diagnosis accuracy and may indicate other serious health conditions requiring treatment.

Red Blood Cell Disorders and Anemia

The most common causes of falsely low HbA1c readings involve conditions that affect red blood cells. Since HbA1c testing relies on measuring glucose attached to hemoglobin in red blood cells, any condition that shortens red blood cell lifespan or alters hemoglobin can lead to misleadingly low results.

Common Causes of Low HbA1c and Their Mechanisms

ConditionMechanismTypical HbA1c ImpactAdditional Testing Needed
Hemolytic AnemiaHemolytic AnemiaShortened RBC lifespanCan lower by 0.5-1.0%CBC, reticulocyte count, haptoglobin
Chronic Blood LossChronic Blood LossIncreased young RBCsVariable reductionIron studies, occult blood test
Liver DiseaseLiver DiseaseMultiple mechanismsCan lower by 0.5-1.5%Liver function tests, albumin
Kidney DiseaseKidney DiseaseUremic toxins, EPO useVariable, often 0.5-1.0% lowerCreatinine, eGFR, urinalysis

RBC = Red Blood Cell, CBC = Complete Blood Count, EPO = Erythropoietin, eGFR = estimated Glomerular Filtration Rate

Hemolytic Anemia

Hemolytic anemia occurs when red blood cells are destroyed faster than they can be produced. This shortened red blood cell lifespan means there's less time for glucose to attach to hemoglobin, resulting in lower HbA1c readings. Common causes include autoimmune disorders, certain medications, infections, and inherited conditions like sickle cell disease or thalassemia.

Iron Deficiency Anemia

While iron deficiency anemia can sometimes cause elevated HbA1c, it can also lead to low readings in certain cases, particularly when there's rapid red blood cell turnover. The relationship between iron status and HbA1c is complex and can vary between individuals. Regular monitoring of both iron levels and HbA1c can help healthcare providers interpret results accurately.

Blood Loss and Hemorrhage

Recent or chronic blood loss can significantly impact HbA1c levels. When you lose blood, your body produces new red blood cells to replace those lost. These younger red blood cells haven't been exposed to glucose for as long, leading to lower HbA1c readings. This can occur with:

  • Heavy menstrual bleeding
  • Gastrointestinal bleeding
  • Recent surgery or trauma
  • Frequent blood donation
  • Internal bleeding from ulcers or other conditions

Liver and Kidney Disease

Both liver and kidney disease can significantly impact HbA1c levels through multiple mechanisms. Understanding these effects is crucial for accurate diabetes monitoring in patients with these conditions.

Chronic Liver Disease

The liver plays a vital role in glucose metabolism and red blood cell production. Chronic liver diseases such as cirrhosis, hepatitis, or fatty liver disease can lead to low HbA1c through several mechanisms:

  • Shortened red blood cell lifespan due to splenomegaly (enlarged spleen)
  • Altered glucose metabolism affecting glycation rates
  • Reduced synthesis of proteins needed for red blood cell production
  • Portal hypertension leading to gastrointestinal bleeding

Patients with liver disease may need alternative methods for monitoring glucose control, as HbA1c may not accurately reflect their average blood sugar levels.

Chronic Kidney Disease

Kidney disease affects HbA1c levels through multiple pathways. Advanced kidney disease can cause low HbA1c readings due to:

  • Shortened red blood cell lifespan from uremic toxins
  • Use of erythropoietin-stimulating agents that increase young red blood cells
  • Chronic inflammation affecting red blood cell production
  • Dialysis-related blood loss and red blood cell damage

Medications That Lower HbA1c

Several medications can interfere with HbA1c measurements or actually lower blood glucose levels, leading to reduced HbA1c readings. It's important to inform your healthcare provider about all medications you're taking when interpreting HbA1c results.

Common Medications Affecting HbA1c

  • Vitamin C (ascorbic acid) in high doses - can interfere with the test methodology
  • Vitamin E supplements - may affect glycation rates
  • Certain antibiotics (dapsone, ribavirin) - can cause hemolysis
  • HIV medications - some antiretrovirals affect red blood cell lifespan
  • Aspirin in high doses - may interfere with glucose attachment to hemoglobin
  • Hydroxyurea - used for sickle cell disease, affects red blood cell production

If you're taking any of these medications, your healthcare provider may need to use alternative methods to assess your glucose control or adjust the interpretation of your HbA1c results. Regular monitoring with multiple testing methods can provide a more complete picture of your metabolic health.

Genetic and Rare Conditions

Several genetic conditions can cause persistently low HbA1c levels, often discovered incidentally during routine testing. These conditions may require specialized testing for accurate diagnosis.

Hemoglobinopathies

Hemoglobinopathies are genetic disorders affecting hemoglobin structure or production. Common examples include:

  • Sickle cell trait or disease - abnormal hemoglobin structure
  • Thalassemia - reduced hemoglobin production
  • Hemoglobin C, D, or E variants - altered hemoglobin properties
  • Hereditary persistence of fetal hemoglobin - presence of fetal hemoglobin in adults

These conditions can cause falsely low HbA1c readings because the abnormal hemoglobin may not glycate at the same rate as normal hemoglobin, or the red blood cells may have a shorter lifespan.

Rare Metabolic Disorders

Certain rare metabolic conditions can also lead to low HbA1c levels:

  • Hereditary fructose intolerance - affects glucose metabolism
  • Galactosemia - impairs glucose processing
  • Glycogen storage diseases - alter glucose regulation
  • Congenital disorders of glycosylation - affect protein glycation

Pregnancy and Hormonal Changes

Pregnancy creates unique physiological changes that can affect HbA1c levels. During pregnancy, red blood cell turnover increases, and blood volume expands, both of which can lead to lower HbA1c readings. This is why alternative glucose monitoring methods are often preferred during pregnancy.

Other hormonal conditions that may influence HbA1c include:

  • Hyperthyroidism - increased metabolic rate and red blood cell turnover
  • Growth hormone deficiency - altered glucose metabolism
  • Adrenal insufficiency - affects glucose regulation
  • Certain pituitary disorders - impact multiple metabolic pathways

When to Be Concerned About Low HbA1c

While low HbA1c itself isn't typically dangerous, it's important to understand what's causing it. You should consult your healthcare provider if:

  • Your HbA1c is consistently below 4.0%
  • You have symptoms of anemia (fatigue, weakness, pale skin, shortness of breath)
  • You're experiencing unexplained weight loss or other concerning symptoms
  • Your HbA1c results don't match your blood glucose meter readings
  • You have a known condition that affects red blood cells
  • You're taking medications that might interfere with the test

Your healthcare provider may recommend additional testing to determine the cause of low HbA1c, including complete blood count (CBC), iron studies, hemoglobin electrophoresis, or liver and kidney function tests.

Alternative Testing Methods

When HbA1c may not be reliable due to conditions causing low readings, alternative methods for assessing glucose control include:

  • Fructosamine - reflects average glucose over 2-3 weeks
  • Glycated albumin - useful in conditions affecting red blood cells
  • Continuous glucose monitoring (CGM) - provides real-time glucose data
  • Self-monitoring blood glucose with regular finger sticks
  • 1,5-anhydroglucitol (1,5-AG) - reflects glucose control over 1-2 weeks

These alternative methods can provide valuable information about glucose control when HbA1c results are unreliable or difficult to interpret.

Taking Action for Better Health Monitoring

Understanding the factors that can cause low HbA1c is crucial for accurate health assessment and diabetes management. If you have conditions that affect your HbA1c readings, work closely with your healthcare provider to develop an appropriate monitoring strategy. This might include more frequent testing, using alternative markers, or combining multiple assessment methods.

Remember that HbA1c is just one piece of the metabolic health puzzle. A comprehensive approach to health monitoring that includes multiple biomarkers, regular check-ups, and attention to symptoms provides the most complete picture of your overall health status. By understanding how various conditions can affect your test results, you can work with your healthcare team to ensure accurate diagnosis and appropriate treatment decisions.

References

  1. Radin, M. S. (2014). Pitfalls in hemoglobin A1c measurement: when results may be misleading. Journal of General Internal Medicine, 29(2), 388-394.[PubMed][DOI]
  2. Sacks, D. B. (2011). A1C versus glucose testing: a comparison. Diabetes Care, 34(2), 518-523.[PubMed][DOI]
  3. Gallagher, E. J., Le Roith, D., & Bloomgarden, Z. (2009). Review of hemoglobin A1c in the management of diabetes. Journal of Diabetes, 1(1), 9-17.[PubMed][DOI]
  4. Little, R. R., & Roberts, W. L. (2009). A review of variant hemoglobins interfering with hemoglobin A1c measurement. Journal of Diabetes Science and Technology, 3(3), 446-451.[PubMed][DOI]
  5. Welsh, K. J., Kirkman, M. S., & Sacks, D. B. (2016). Role of glycated proteins in the diagnosis and management of diabetes: research gaps and future directions. Diabetes Care, 39(8), 1299-1306.[PubMed][DOI]
  6. Bloomgarden, Z. (2009). A1C: recommendations, debates, and questions. Diabetes Care, 32(12), e141-e147.[PubMed][DOI]

Frequently Asked Questions

How can I test my HbA1c at home?

You can test your HbA1c at home with SiPhox Health's Core Health Program, which includes HbA1c testing along with other essential metabolic and cardiovascular biomarkers. This CLIA-certified program provides lab-quality results from the comfort of your home, helping you track your metabolic health over time.

What is considered a dangerously low HbA1c level?

While there's no universally agreed upon "dangerous" low level, HbA1c below 4.0% is generally considered abnormally low and warrants investigation. In people without diabetes who aren't taking glucose-lowering medications, very low HbA1c usually indicates an underlying condition affecting red blood cells rather than dangerously low blood sugar.

Can low HbA1c cause symptoms?

Low HbA1c itself doesn't cause symptoms, but the underlying conditions causing it often do. For example, if anemia is causing low HbA1c, you might experience fatigue, weakness, dizziness, or shortness of breath. The symptoms you experience will depend on what's causing the low reading.

How often should I retest if I have low HbA1c?

The frequency of retesting depends on the underlying cause and your overall health status. If you have a condition known to affect HbA1c, your healthcare provider might recommend alternative testing methods or more frequent monitoring. Generally, testing every 3-6 months is appropriate for tracking changes, but your doctor may suggest a different schedule based on your specific situation.

Can diet affect HbA1c levels in people without diabetes?

Yes, diet can influence HbA1c levels even in people without diabetes. A diet very low in carbohydrates might lead to slightly lower HbA1c readings, while a diet high in processed foods and sugars could cause higher readings. However, dietary changes alone rarely cause abnormally low HbA1c levels below 4.0%.

Related Articles

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details